Literature DB >> 3929407

Parents of infants with ophthalmia neonatorum: a high-risk group for sexually transmitted diseases.

L Fransen, H Nsanze, L J D'Costa, R C Brunham, P Piot.   

Abstract

One hundred forty-nine mothers and 74 fathers of infants who presented at the Special Treatment Clinic (Nairobi) with ophthalmia neonatorum were evaluated. Neisseria gonorrhoeae was isolated from 60 (40%) of 149 mothers and Chlamydia trachomatis was isolated from 31 (21%). Twenty-six mothers (17.5%) had clinical evidence of endometritis or pelvic inflammatory disease. Mothers with endometritis and/or pelvic inflammatory disease were more often infected with N. gonorrhoeae (65%) than were mothers without these conditions (24%) (P less than or equal to .001). N. gonorrhoeae was isolated from ten (14%) and C. trachomatis from three (9%) of 32 fathers, and nongonococcal urethritis was diagnosed in an additional 21 fathers (28%). Seven of ten men with gonococcal urethritis and 18 of 21 with nongonococcal urethritis had no symptoms. These data confirm that the presence of ophthalmia neonatorum in a neonate should be considered as a strong indicator of sexually transmitted disease in the parents. Although most infections in fathers were asymptomatic, the mothers were at high risk for complications.

Entities:  

Mesh:

Year:  1985        PMID: 3929407     DOI: 10.1097/00007435-198507000-00011

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN: 0148-5717            Impact factor:   2.830


  3 in total

1.  Diagnosis of ophthalmia neonatorum.

Authors:  J Winceslaus; B T Goh; E M Dunlop; J Mantell; R M Woodland; T Forsey; J D Treharne
Journal:  Br Med J (Clin Res Ed)       Date:  1987-11-28

Review 2.  Sexually transmitted diseases in children: chlamydial oculo-genital infection.

Authors:  B T Goh; G E Forster
Journal:  Genitourin Med       Date:  1993-06

Review 3.  Neonatal ophthalmia in the developing world. Epidemiology, etiology, management and control.

Authors:  L Fransen; V Klauss
Journal:  Int Ophthalmol       Date:  1988-01       Impact factor: 2.031

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.